Maplebear (NASDAQ:CART) vs. Raia Drogasil (OTCMKTS:RADLY) Head-To-Head Comparison

Maplebear (NASDAQ:CART – Get Free Report) and Raia Drogasil (OTCMKTS:RADLY – Get Free Report) are both consumer staples companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership.

Earnings and Valuation

This table compares Maplebear and Raia Drogasil”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Maplebear $3.74 billion 3.06 $447.00 million $1.83 27.00
Raia Drogasil $7.92 billion 0.67 $232.27 million $0.05 80.20

Maplebear has higher earnings, but lower revenue than Raia Drogasil. Maplebear is trading at a lower price-to-earnings ratio than Raia Drogasil, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

63.1% of Maplebear shares are owned by institutional investors. 24.0% of Maplebear shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Profitability

This table compares Maplebear and Raia Drogasil’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Maplebear 11.97% 20.19% 14.13%
Raia Drogasil 2.99% 20.12% 5.88%

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Maplebear and Raia Drogasil, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Maplebear 0 6 14 0 2.70
Raia Drogasil 0 1 0 0 2.00

Maplebear presently has a consensus target price of $58.24, suggesting a potential upside of 17.85%. Given Maplebear’s stronger consensus rating and higher possible upside, analysts plainly believe Maplebear is more favorable than Raia Drogasil.

Summary

Maplebear beats Raia Drogasil on 12 of the 13 factors compared between the two stocks.

About Maplebear

(Get Free Report)

Maplebear Inc., doing business as Instacart, engages in the provision of online grocery shopping services to households in North America. It sells and delivers grocery products, as well as pickup services through a mobile application and website. It also operates virtual convenience stores; and provides software-as-a-service solutions to retailers. The company was incorporated in 2012 and is based in San Francisco, California.

About Raia Drogasil

(Get Free Report)

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It also markets its goods through telesales and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

Receive News & Ratings for Maplebear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maplebear and related companies with MarketBeat.com's FREE daily email newsletter.